Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

This project explores the application of recursive neural networks (RNNs) in natural language processing, specifically for part-of-speech (POS) tagging. Drawing on foundational work by Socher et al.

The gunman who shot and killed an NYPD officer and three other people in midtown Manhattan on Monday carried a handwritten note claiming he had CTE — a degenerative brain disease that is the result of ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Obsidian Middle School has been awarded $15,000 to create a Career and Technical Education learning space out from the SELCO Community Credit Union Steps Up initiative. The project was decided on by ...

Abstract: In this paper, recursive least-squares linear estimation algorithms are proposed for stochastic systems influenced by uniform quantization, random access protocol (RAP) and deception attacks ...

Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...